Arcellx (ACLX) Shares Outstanding (2021 - 2025)
Arcellx (ACLX) recorded quarterly Shares Outstanding of $57.9 million in Q4 2025, little changed quarter-over-quarter from $57.8 million in Q3 2025, and up 6.7% on a YoY basis from $54.3 million in Q4 2024.
Arcellx (ACLX) Shares Outstanding (2021 - 2025) Analysis & Trends
Arcellx's Shares Outstanding history runs 5 years deep, the most recent figure standing at $57.9 million for Q4 2025.
- In Q4 2025, Shares Outstanding rose 6.7% year-over-year to $57.9 million; the TTM figure through Dec 2025 stood at $57.9 million (up 6.7% YoY), while the FY2025 annual figure was $57.9 million, up 6.7% from the prior year.
- Shares Outstanding was $57.9 million for Q4 2025 at Arcellx, roughly flat from $57.8 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $57.9 million in Q4 2025 to a low of $348353.0 in Q1 2021.
- Historically, Shares Outstanding has averaged $40.4 million across 5 years, with a median of $48.5 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding surged 10153.61% in 2022, then gained 3.24% in 2025.
- A 5-year view of Shares Outstanding shows it stood at $544210.0 in 2021, then jumped by 8004.59% to $44.1 million in 2022, then climbed by 18.53% to $52.3 million in 2023, then advanced by 3.85% to $54.3 million in 2024, then rose by 6.7% to $57.9 million in 2025.
- The last three Shares Outstanding figures came in at $57.9 million (Q4 2025), $57.8 million (Q3 2025), and $55.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 91.57 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 57.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57.93 Mn |
| Dec 31, 2025 | 57.93 Mn |
| Dec 31, 2025 | 57.93 Mn |
| Dec 31, 2025 | 57.93 Mn |
| Dec 31, 2025 | 57.93 Mn |
| Dec 31, 2025 | 57.93 Mn |
| Dec 31, 2025 | 57.93 Mn |
| Dec 31, 2025 | 57.93 Mn |
| Sep 30, 2025 | 57.78 Mn |
| Sep 30, 2025 | 57.78 Mn |
| Sep 30, 2025 | 57.78 Mn |
| Sep 30, 2025 | 57.78 Mn |
| Sep 30, 2025 | 57.78 Mn |
| Sep 30, 2025 | 57.78 Mn |
| Sep 30, 2025 | 57.78 Mn |
| Sep 30, 2025 | 57.78 Mn |
| Jun 30, 2025 | 55.37 Mn |
| Jun 30, 2025 | 55.37 Mn |
| Jun 30, 2025 | 55.37 Mn |
| Jun 30, 2025 | 55.37 Mn |